<<<<<<< HEAD
<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 2; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l6 {padding-left: 0pt;counter-reset: e2 1; }
 #l6> li>*:first-child:before {counter-increment: e2; content: counter(e2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: e2 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: f1 2; }
 #l7> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l8 {padding-left: 0pt;counter-reset: f2 1; }
 #l8> li>*:first-child:before {counter-increment: f2; content: counter(f2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: g1 1; }
 #l9> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: g1 0;  }
</style></head><body><p class="s1" style="padding-top: 3pt;padding-left: 93pt;text-indent: 0pt;text-align: left;">PHARMACY  PRACTICE  (MPP)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 6pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">CLINICAL PHARMACY PRACTICE (MPP 101T)</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: justify;">This course is designed to impart the basic knowledge and skills that are required to practice pharmacy including the provision of pharmaceutical care services to both healthcare professionals and patients in clinical settings.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of this course it is expected that students shall be able to :</p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">Understand the elements of pharmaceutical care and provide comprehensive patient care services</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 89%;text-align: left;">  <span class="p">Interpret the laboratory results to aid the clinical diagnosis of various disorders</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 90%;text-align: left;">  <span class="p">Provide integrated, critically analyzed medicine and poison information to enable healthcare professionals in the efficient patient management</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">Introduction to Clinical Pharmacy:  </span>Definition, evolution and scope of clinical pharmacy, International and national scenario of clinical pharmacy practice, Pharmaceutical care</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Clinical Pharmacy Services: <span class="p">Ward round participation, Drug therapy review (Drug therapy monitoring including medication order review, chart endorsement, clinical review and pharmacist interventions)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 85%;text-align: justify;">Clinical Pharmacy  Services:  <span class="p">Patient  medication  history interview, Basic concept of medicine and poison information services, Basic concept of pharmacovigilance, Hemovigilance, Materiovigilance and AEFI, Patient medication counselling, Drug utilisation evaluation, Documentation of clinical pharmacy services</span>, <span class="p">Quality assurance of clinical pharmacy services.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Patient Data Analysis:</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Patient Data &amp; Practice Skills: <span class="p">Patient&#39;s case history - its</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">structure and significances in drug therapy management, Common medical abbreviations and terminologies used in clinical practice<span class="s2">, </span>Communication skills: verbal and non-verbal communications, its applications in patient care services.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: left;">Lab Data Interpretation: <span class="p">Hematological tests</span>, <span class="p">Renal function tests</span>, <span class="p">Liver function tests</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 85%;text-align: justify;">Lab Data Interpretation: <span class="p">Tests associated  with  cardiac disorders, Pulmonary function tests</span>, <span class="p">Thyroid function tests</span>, <span class="p">Fluid and electrolyte balance</span>, <span class="p">Microbiological culture sensitivity tests</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 28pt;text-indent: -22pt;line-height: 12pt;text-align: left;">Medicines &amp; Poison Information Services</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Medicine Information Service: <span class="p">Definition and need for medicine</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">information service, Medicine information resources, Systematic approach in answering medicine information queries, Preparation of verbal and written response, Establishing a drug information centre.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Poison Information Service: <span class="p">Definition, need, organization and functions of poison information centre.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l2"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">A Textbook of Clinical Pharmacy Practice – Essential concepts and skills – Parthasarathi G, Karin Nyfort-Hansen and Milap Nahata</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Practice Standards and Definitions - The Society of Hospital Pharmacists of Australia</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Basic skills in interpreting laboratory data - Scott LT, American Society of Health System Pharmacists Inc</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Relevant review articles from recent medical and pharmaceutical literature.</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 138pt;text-indent: -44pt;line-height: 113%;text-align: left;">PHARMACOTHERAPEUTICS-I (MPP 102T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course aims to enable the students to understand the different treatment approaches in managing various disease conditions. Also, it imparts knowledge and skills in optimizing drug therapy of a patient by individualizing the treatment plan through evidence-based medicines.</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Objectives</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Upon completion of this course it is expected that students shall be able to:</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">  <span class="p">Describe and explain the rationale for drug therapy</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">Summarize the therapeutic approach for management of various disease conditions including reference to the latest available evidence</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">Discuss the clinical controversies in drug therapy and evidence based medicine</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">  <span class="p">Prepare individualized therapeutic plans based on diagnosis</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: justify;"> <span class="p">Identify the patient specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time- course of clinical and laboratory indices of therapeutic response and adverse effect/s)</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 110%;text-align: left;">Etiopathogenesis  and  pharmacotherapy  of  diseases associated with following systems</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">1.  <span class="s2">Cardiovascular system: </span>Hypertension, Congestive cardiac failure, Acute coronary syndrome, Arrhythmias, Hyperlipidemias.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l3"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: left;">Respiratory system: <span class="p">Asthma, Chronic obstructive airways disease, Drug induced pulmonary diseases</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Endocrine system: <span class="p">Diabetes, Thyroid diseases</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 88%;text-align: left;">Gastrointestinal  system:  <span class="p">Peptic ulcer diseases, Reflux esophagitis, Inflammatory bowel diseases, Jaundice &amp; hepatitis</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Gastrointestinal system: <span class="p">Cirrhosis, Diarrhea and Constipation, Drug-induced liver disease</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: left;">Hematological diseases: <span class="p">Anemia, Deep vein thrombosis, Drug induced hematological disorders</span></p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: left;">Bone and joint disorders: <span class="p">Rheumatoid arthritis, Osteoarthritis, Gout, Osteoporosis</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: left;">Dermatological Diseases: <span class="p">Psoriasis, Eczema and scabies, impetigo, drug induced skin disorders</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;text-align: left;">Ophthalmology: <span class="p">Conjunctivitis, Glaucoma</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l4"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 26pt;text-indent: -14pt;line-height: 74%;text-align: left;">Roger and Walker. Clinical Pharmacy and Therapeutics - Churchill Livingstone publication</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Joseph T. Dipiro et al. Pharmacotherapy: A Pathophysiologic Approach- Appleton &amp; Lange</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Robins SL. Pathologic basis of disease -W.B. Saunders publication</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Eric T. Herfindal. Clinical Pharmacy and Therapeutics- Williams and Wilkins Publication</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Lloyd Young and Koda-Kimble MA Applied Therapeutics: The clinical Use of Drugs- Lippincott Williams and Wilkins</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Chisholm- Burns Wells Schwinghammer Malone and Joseph P Dipiro. Pharmacotherapy Principles and practice-– McGraw Hill Publication</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Carol Mattson Porth. Principles of Pathophysiology- Lippincott Williams and Wilkins</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Harrison&#39;s. Principles of Internal Medicine - McGraw Hill</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Relevant review articles from recent medical and pharmaceutical literature</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 138pt;text-indent: -65pt;line-height: 113%;text-align: left;">HOSPITAL &amp; COMMUNITY PHARMACY (MPP 103T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This course is designed to impart basic knowledge and skills that are required to practice pharmacy in both hospital and community settings.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;line-height: 13pt;text-align: center;">Upon completion of this course it is expected that students shall be able to:</p><p class="s2" style="padding-left: 4pt;text-indent: 0pt;line-height: 12pt;text-align: center;">  <span class="p">Understand the organizational structure of hospital pharmacy</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Understand drug policy and drug committees</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know about procurement &amp; drug distribution practices</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know the admixtures of radiopharmaceuticals</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Understand the community pharmacy management</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know about value added services in community pharmacies</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 89%;text-align: justify;">1.  <span class="s2">Introduction  to  Hospitals  </span>–  Definition,  classification, organizational structure</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Hospital Pharmacy: <span class="p">Definition, Relationship of  hospital pharmacy department with other departments, Organizational structure, legal requirements, work load statistics, Infrastructural requirements, Hospital Pharmacy Budget and Hospital Pharmacy management</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Hospital Drug Policy: <span class="p">Pharmacy &amp; Therapeutics Committee,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Infection Control committee, Research &amp; Ethics Committee, Management of Medicines as per NABH</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l5"><li data-list-text="2"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Hospital Formulary Guidelines and its development, Developing Therapeutic guidelines, Drug procurement process, and methods of Inventory control, Methods of Drug distribution, Intravenous admixtures, Hospital Waste Management</p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Education and training: <span class="p">Training of technical staff, training and continuing education for pharmacists, Pharmacy students, Medical staff and students, Nursing staff and students, Formal and informal meetings and lectures, Drug and therapeutics newsletter.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Community  Pharmacy  Practice:  <span class="p">Definition,  roles  &amp; responsibilities of community pharmacists, and their relationship with other health care providers.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Community Pharmacy  management:  <span class="p">Legal requirements  to start community pharmacy, site selection, lay out &amp; design, drug display, super drug store model, accounts and audits, Good dispensing practices, Different softwares &amp; databases used in community pharmacies. Entrepreneurship in community pharmacy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Prescription <span class="p">– Legal requirements &amp; interpretation, prescription related problems</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 91%;text-align: left;">Responding to symptoms of minor ailments: <span class="p">Head ache, pyrexia, menstrual pains, food and drug allergy,</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">OTC medication: <span class="p">Rational use of over the counter medications</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: left;">Medication counseling and use of patient information leaflets Medication adherence – Definition, factors influencing adherence behavior, strategies to improve medication adherence</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Patient referrals to the doctors</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ADR monitoring in community pharmacies</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Health Promotion <span class="p">– Definition and health promotion activities, family planning, Health screening services, first aid, prevention of communicable and non-communicable diseases, smoking cessation, Child &amp; mother care</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 10pt;text-align: left;">National Health Programs<span class="p">- Role of Community Pharmacist in</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Malaria and TB control programs</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: left;">Home Medicines review program <span class="p">– Definition, objectives, Guidelines, method and outcomes</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Research in community pharmacy Practice</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l6"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Hospital Pharmacy - Hassan WE. Lea and Febiger publication.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Textbook of hospital pharmacy - Allwood MC and Blackwell.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Avery’s Drug Treatment, Adis International Limited.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Community Pharmacy Practice – Ramesh Adepu, BSP Publishers, Hyderabad</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Remington Pharmaceutical Sciences.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Relevant review articles from recent medical and pharmaceutical literature</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 115pt;text-indent: 0pt;line-height: 113%;text-align: center;">CLINICAL RESEARCH (MPP 104T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course aims to provide the students an opportunity to learn drug development process especially the phases of clinical trials and also the ethical issues involved in the conduct of clinical research. Also, it aims to imparts knowledge and develop skills on conceptualizing, designing, conducting and managing clinical trials.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of this course it is expected that students shall be able to:</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Know the new drug development process.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Understand the regulatory and ethical requirements.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Appreciate and conduct the clinical trials activities</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know safety monitoring and reporting in clinical trials</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Manage the trial coordination process</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">1.  <span class="s2">Drug development process</span>: Introduction, various approaches to drug discovery, Investigational new drug application submission Ethics in Biomedical Research: Ethical Issues in Biomedical Research – Principles of ethics in biomedical research, Ethical committee [institutional review board] - its constitution and functions, Challenges in implementation of ethical guidelines, ICH GCP guidelines and ICMR guidelines in conduct of Clinical trials, Drug Safety Reporting.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l7"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Types and Designs used in Clinical Research: <span class="p">Planning and execution of clinical trials, Various Phases of clinical trials, Bioavailability and Bioequivalence studies, Randomization techniques (Simple randomization, restricted randomization, blocking method and stratification), Types of research designs based on Controlling Method (Experimental, Quasi experimental, and Observational methods) Time Sequences (Prospective and Retrospective), Sampling methods (Cohort study, case Control study and cross sectional study), Health outcome measures (Clinical &amp; Physiological, Humanistic and economic)</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Clinical Trial Study team: <span class="p">Roles and responsibilities of:</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Investigator, Study Coordinator, Sponsor, Monitor, Contract Research Organization.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Clinical trial Documents: <span class="p">Guidelines to the preparation of following documents: Protocols, Investigator’s Brochure, Informed Consent Form, Case report forms, Contracts and agreements, Dairy Cards</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Clinical Trial Start up activities: <span class="p">Site Feasibility Studies</span>, <span class="p">Site/Investigator selection</span>, <span class="p">Pre-study visit</span>, <span class="p">Investigator meeting</span>, <span class="p">Clinical trial agreement execution</span>, <span class="p">Ethics committee document preparation and submission</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Investigational  Product:  <span class="p">Procurement  and  Storage  of investigation product</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 91%;text-align: justify;">Filing procedures<span class="p">: Essential documents for clinical trial, Trial Master File preparation and maintenance, Investigator Site File, Pharmacy File, Site initiation visit, Conduct, Report and Follow up</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 6pt;text-align: justify;">Clinical Trial Monitoring and Close out:</p><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Preparation and conduct of monitoring visit: <span class="p">Review of source documents, CRF, ICF, IP storage, accountability and reconciliation, Study Procedure, EC communications, Safety reporting, Monitoring visit reporting and follow-up</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Close-Out visit<span class="p">: Study related documents collection, Archival</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">requirement, Investigational Product reconciliation and destruction, Close-Out visit report.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Quality Assurance and Quality Control in  Clinical  Trials: <span class="p">Types of audits, Audit criteria, Audit process</span>, <span class="p">Responsibilities of stakeholders in audit process</span>, <span class="p">Audit follow-up and documentation, Audit resolution and Preparing for FDA inspections, Fraud and misconduct management</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 7pt;text-align: justify;">Data Management</p><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;text-align: justify;">Infrastructure   and   System   Requirement   for   Data Management: <span class="p">Electronic data capture systems</span>, <span class="p">Selection and implementation of new systems</span>, <span class="p">System validation and test</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 84%;text-align: left;">procedures, Coding dictionaries<span class="s2">, </span>Data migration and archival <span class="s2">Clinical  Trial  Data  Management:  </span>Standard  Operating Procedures, Data management plan, CRF &amp; Data base design considerations, Study set-up, Data entry, CRF tracking and corrections, Data cleaning<span class="s2">, </span>Managing laboratory and ADR data<span class="s2">, </span>Data transfer and database lock<span class="s2">, </span>Quality Control and Quality Assurance in CDM<span class="s2">, </span>Data mining and warehousing.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l8"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 26pt;text-indent: -14pt;line-height: 79%;text-align: justify;">Principles and practice of pharmaceutical medicine, Second edition. Authors:Lionel. D. Edward, Aadrew.J.Flether Anthony W Fos , Peter D Sloaier Publisher:Wiley;</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Handbook of clinical research. Julia Lloyd and Ann Raven Ed. Churchill Livingstone</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Principles of Clinical Research edited by Giovanna di Ignazio, Di Giovanna and Haynes.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Central Drugs Standard Control Organization. Good Clinical Practices- Guidelines for Clinical Trials on Pharmaceutical Products in India. New Delhi: Ministry of Health.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">International Conference on Harmonisation of Technical requirements for registration of Pharmaceuticals for human use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice.E6; May 1996.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Ethical Guidelines for Biomedical Research on Human Subjects. Indian Council of Medical Research, New Delhi.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Textbook of Clinical Trials edited by David Machin, Simon Day and Sylvan Green, John Wiley and Sons.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Clinical Data Management edited by R K Rondels, S A Varley, C F Webbs. Second Edition, Jan 2000, Wiley Publications.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: justify;">Goodman &amp; Gilman: JG Hardman, LE Limbard, McGraw Hill Publications.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: justify;">Relevant review articles from recent medical and pharmaceutical literature.</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 141pt;text-indent: -65pt;line-height: 113%;text-align: left;">PHARMACY PRACTICE PRACTICAL – I (MPP 105P)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Pharmacy Practice practical component includes experiments covering important topics of the courses  Clinical Pharmacy Practice, Pharmacotherapeutics-I, Hospital &amp; Community Pharmacy and Clinical Research.</p><p class="s2" style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">List of Experiments (24)</p><ol id="l9"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Treatment Chart Review (one)</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 11pt;text-align: left;">Medication History Interview (one)</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Patient Medication Counseling (two)</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Drug Information Query (two)</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Poison Information Query (one)</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Lab Data Interpretation (two)</p></li><li data-list-text="7."><p style="padding-left: 27pt;text-indent: -18pt;line-height: 86%;text-align: left;">Presentation of clinical cases of various disease conditions adopting Pharmaceutical Care Plan Model (eight)</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 11pt;text-align: left;">ABC Analysis of a given list of medications (one)</p></li><li data-list-text="9."><p style="padding-top: 1pt;padding-left: 27pt;text-indent: -18pt;line-height: 85%;text-align: left;">Preparation of content of a medicine, with proper justification, for the inclusion in the hospital formulary (one)</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 11pt;text-align: left;">Formulation and dispensing of a given IV admixtures (one)</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of a patient information leaflet (two)</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of Study Protocol (one)</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Preparation of Informed Consent Form (one)</p></li></ol></body></html>
=======
<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 2; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l6 {padding-left: 0pt;counter-reset: e2 1; }
 #l6> li>*:first-child:before {counter-increment: e2; content: counter(e2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: e2 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: f1 2; }
 #l7> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l8 {padding-left: 0pt;counter-reset: f2 1; }
 #l8> li>*:first-child:before {counter-increment: f2; content: counter(f2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: g1 1; }
 #l9> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: g1 0;  }
</style></head><body><p class="s1" style="padding-top: 3pt;padding-left: 93pt;text-indent: 0pt;text-align: left;">PHARMACY  PRACTICE  (MPP)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 6pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">CLINICAL PHARMACY PRACTICE (MPP 101T)</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: justify;">This course is designed to impart the basic knowledge and skills that are required to practice pharmacy including the provision of pharmaceutical care services to both healthcare professionals and patients in clinical settings.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of this course it is expected that students shall be able to :</p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">Understand the elements of pharmaceutical care and provide comprehensive patient care services</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 89%;text-align: left;">  <span class="p">Interpret the laboratory results to aid the clinical diagnosis of various disorders</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 90%;text-align: left;">  <span class="p">Provide integrated, critically analyzed medicine and poison information to enable healthcare professionals in the efficient patient management</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">Introduction to Clinical Pharmacy:  </span>Definition, evolution and scope of clinical pharmacy, International and national scenario of clinical pharmacy practice, Pharmaceutical care</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Clinical Pharmacy Services: <span class="p">Ward round participation, Drug therapy review (Drug therapy monitoring including medication order review, chart endorsement, clinical review and pharmacist interventions)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 85%;text-align: justify;">Clinical Pharmacy  Services:  <span class="p">Patient  medication  history interview, Basic concept of medicine and poison information services, Basic concept of pharmacovigilance, Hemovigilance, Materiovigilance and AEFI, Patient medication counselling, Drug utilisation evaluation, Documentation of clinical pharmacy services</span>, <span class="p">Quality assurance of clinical pharmacy services.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Patient Data Analysis:</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Patient Data &amp; Practice Skills: <span class="p">Patient&#39;s case history - its</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">structure and significances in drug therapy management, Common medical abbreviations and terminologies used in clinical practice<span class="s2">, </span>Communication skills: verbal and non-verbal communications, its applications in patient care services.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: left;">Lab Data Interpretation: <span class="p">Hematological tests</span>, <span class="p">Renal function tests</span>, <span class="p">Liver function tests</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 85%;text-align: justify;">Lab Data Interpretation: <span class="p">Tests associated  with  cardiac disorders, Pulmonary function tests</span>, <span class="p">Thyroid function tests</span>, <span class="p">Fluid and electrolyte balance</span>, <span class="p">Microbiological culture sensitivity tests</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 28pt;text-indent: -22pt;line-height: 12pt;text-align: left;">Medicines &amp; Poison Information Services</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Medicine Information Service: <span class="p">Definition and need for medicine</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">information service, Medicine information resources, Systematic approach in answering medicine information queries, Preparation of verbal and written response, Establishing a drug information centre.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Poison Information Service: <span class="p">Definition, need, organization and functions of poison information centre.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l2"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">A Textbook of Clinical Pharmacy Practice – Essential concepts and skills – Parthasarathi G, Karin Nyfort-Hansen and Milap Nahata</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Practice Standards and Definitions - The Society of Hospital Pharmacists of Australia</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Basic skills in interpreting laboratory data - Scott LT, American Society of Health System Pharmacists Inc</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Relevant review articles from recent medical and pharmaceutical literature.</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 138pt;text-indent: -44pt;line-height: 113%;text-align: left;">PHARMACOTHERAPEUTICS-I (MPP 102T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course aims to enable the students to understand the different treatment approaches in managing various disease conditions. Also, it imparts knowledge and skills in optimizing drug therapy of a patient by individualizing the treatment plan through evidence-based medicines.</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Objectives</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Upon completion of this course it is expected that students shall be able to:</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">  <span class="p">Describe and explain the rationale for drug therapy</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">Summarize the therapeutic approach for management of various disease conditions including reference to the latest available evidence</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">Discuss the clinical controversies in drug therapy and evidence based medicine</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">  <span class="p">Prepare individualized therapeutic plans based on diagnosis</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: justify;"> <span class="p">Identify the patient specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time- course of clinical and laboratory indices of therapeutic response and adverse effect/s)</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 110%;text-align: left;">Etiopathogenesis  and  pharmacotherapy  of  diseases associated with following systems</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">1.  <span class="s2">Cardiovascular system: </span>Hypertension, Congestive cardiac failure, Acute coronary syndrome, Arrhythmias, Hyperlipidemias.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l3"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: left;">Respiratory system: <span class="p">Asthma, Chronic obstructive airways disease, Drug induced pulmonary diseases</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Endocrine system: <span class="p">Diabetes, Thyroid diseases</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 88%;text-align: left;">Gastrointestinal  system:  <span class="p">Peptic ulcer diseases, Reflux esophagitis, Inflammatory bowel diseases, Jaundice &amp; hepatitis</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Gastrointestinal system: <span class="p">Cirrhosis, Diarrhea and Constipation, Drug-induced liver disease</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: left;">Hematological diseases: <span class="p">Anemia, Deep vein thrombosis, Drug induced hematological disorders</span></p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: left;">Bone and joint disorders: <span class="p">Rheumatoid arthritis, Osteoarthritis, Gout, Osteoporosis</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: left;">Dermatological Diseases: <span class="p">Psoriasis, Eczema and scabies, impetigo, drug induced skin disorders</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;text-align: left;">Ophthalmology: <span class="p">Conjunctivitis, Glaucoma</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l4"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 26pt;text-indent: -14pt;line-height: 74%;text-align: left;">Roger and Walker. Clinical Pharmacy and Therapeutics - Churchill Livingstone publication</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Joseph T. Dipiro et al. Pharmacotherapy: A Pathophysiologic Approach- Appleton &amp; Lange</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Robins SL. Pathologic basis of disease -W.B. Saunders publication</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Eric T. Herfindal. Clinical Pharmacy and Therapeutics- Williams and Wilkins Publication</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Lloyd Young and Koda-Kimble MA Applied Therapeutics: The clinical Use of Drugs- Lippincott Williams and Wilkins</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Chisholm- Burns Wells Schwinghammer Malone and Joseph P Dipiro. Pharmacotherapy Principles and practice-– McGraw Hill Publication</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Carol Mattson Porth. Principles of Pathophysiology- Lippincott Williams and Wilkins</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Harrison&#39;s. Principles of Internal Medicine - McGraw Hill</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Relevant review articles from recent medical and pharmaceutical literature</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 138pt;text-indent: -65pt;line-height: 113%;text-align: left;">HOSPITAL &amp; COMMUNITY PHARMACY (MPP 103T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This course is designed to impart basic knowledge and skills that are required to practice pharmacy in both hospital and community settings.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;line-height: 13pt;text-align: center;">Upon completion of this course it is expected that students shall be able to:</p><p class="s2" style="padding-left: 4pt;text-indent: 0pt;line-height: 12pt;text-align: center;">  <span class="p">Understand the organizational structure of hospital pharmacy</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Understand drug policy and drug committees</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know about procurement &amp; drug distribution practices</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know the admixtures of radiopharmaceuticals</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Understand the community pharmacy management</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know about value added services in community pharmacies</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 89%;text-align: justify;">1.  <span class="s2">Introduction  to  Hospitals  </span>–  Definition,  classification, organizational structure</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Hospital Pharmacy: <span class="p">Definition, Relationship of  hospital pharmacy department with other departments, Organizational structure, legal requirements, work load statistics, Infrastructural requirements, Hospital Pharmacy Budget and Hospital Pharmacy management</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Hospital Drug Policy: <span class="p">Pharmacy &amp; Therapeutics Committee,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Infection Control committee, Research &amp; Ethics Committee, Management of Medicines as per NABH</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l5"><li data-list-text="2"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Hospital Formulary Guidelines and its development, Developing Therapeutic guidelines, Drug procurement process, and methods of Inventory control, Methods of Drug distribution, Intravenous admixtures, Hospital Waste Management</p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Education and training: <span class="p">Training of technical staff, training and continuing education for pharmacists, Pharmacy students, Medical staff and students, Nursing staff and students, Formal and informal meetings and lectures, Drug and therapeutics newsletter.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Community  Pharmacy  Practice:  <span class="p">Definition,  roles  &amp; responsibilities of community pharmacists, and their relationship with other health care providers.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Community Pharmacy  management:  <span class="p">Legal requirements  to start community pharmacy, site selection, lay out &amp; design, drug display, super drug store model, accounts and audits, Good dispensing practices, Different softwares &amp; databases used in community pharmacies. Entrepreneurship in community pharmacy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Prescription <span class="p">– Legal requirements &amp; interpretation, prescription related problems</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 91%;text-align: left;">Responding to symptoms of minor ailments: <span class="p">Head ache, pyrexia, menstrual pains, food and drug allergy,</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">OTC medication: <span class="p">Rational use of over the counter medications</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: left;">Medication counseling and use of patient information leaflets Medication adherence – Definition, factors influencing adherence behavior, strategies to improve medication adherence</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Patient referrals to the doctors</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ADR monitoring in community pharmacies</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Health Promotion <span class="p">– Definition and health promotion activities, family planning, Health screening services, first aid, prevention of communicable and non-communicable diseases, smoking cessation, Child &amp; mother care</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 10pt;text-align: left;">National Health Programs<span class="p">- Role of Community Pharmacist in</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Malaria and TB control programs</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: left;">Home Medicines review program <span class="p">– Definition, objectives, Guidelines, method and outcomes</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Research in community pharmacy Practice</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l6"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Hospital Pharmacy - Hassan WE. Lea and Febiger publication.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Textbook of hospital pharmacy - Allwood MC and Blackwell.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Avery’s Drug Treatment, Adis International Limited.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Community Pharmacy Practice – Ramesh Adepu, BSP Publishers, Hyderabad</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Remington Pharmaceutical Sciences.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Relevant review articles from recent medical and pharmaceutical literature</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 115pt;text-indent: 0pt;line-height: 113%;text-align: center;">CLINICAL RESEARCH (MPP 104T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course aims to provide the students an opportunity to learn drug development process especially the phases of clinical trials and also the ethical issues involved in the conduct of clinical research. Also, it aims to imparts knowledge and develop skills on conceptualizing, designing, conducting and managing clinical trials.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of this course it is expected that students shall be able to:</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Know the new drug development process.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Understand the regulatory and ethical requirements.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Appreciate and conduct the clinical trials activities</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Know safety monitoring and reporting in clinical trials</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Manage the trial coordination process</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">1.  <span class="s2">Drug development process</span>: Introduction, various approaches to drug discovery, Investigational new drug application submission Ethics in Biomedical Research: Ethical Issues in Biomedical Research – Principles of ethics in biomedical research, Ethical committee [institutional review board] - its constitution and functions, Challenges in implementation of ethical guidelines, ICH GCP guidelines and ICMR guidelines in conduct of Clinical trials, Drug Safety Reporting.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l7"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Types and Designs used in Clinical Research: <span class="p">Planning and execution of clinical trials, Various Phases of clinical trials, Bioavailability and Bioequivalence studies, Randomization techniques (Simple randomization, restricted randomization, blocking method and stratification), Types of research designs based on Controlling Method (Experimental, Quasi experimental, and Observational methods) Time Sequences (Prospective and Retrospective), Sampling methods (Cohort study, case Control study and cross sectional study), Health outcome measures (Clinical &amp; Physiological, Humanistic and economic)</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Clinical Trial Study team: <span class="p">Roles and responsibilities of:</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Investigator, Study Coordinator, Sponsor, Monitor, Contract Research Organization.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Clinical trial Documents: <span class="p">Guidelines to the preparation of following documents: Protocols, Investigator’s Brochure, Informed Consent Form, Case report forms, Contracts and agreements, Dairy Cards</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Clinical Trial Start up activities: <span class="p">Site Feasibility Studies</span>, <span class="p">Site/Investigator selection</span>, <span class="p">Pre-study visit</span>, <span class="p">Investigator meeting</span>, <span class="p">Clinical trial agreement execution</span>, <span class="p">Ethics committee document preparation and submission</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Investigational  Product:  <span class="p">Procurement  and  Storage  of investigation product</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 91%;text-align: justify;">Filing procedures<span class="p">: Essential documents for clinical trial, Trial Master File preparation and maintenance, Investigator Site File, Pharmacy File, Site initiation visit, Conduct, Report and Follow up</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 6pt;text-align: justify;">Clinical Trial Monitoring and Close out:</p><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Preparation and conduct of monitoring visit: <span class="p">Review of source documents, CRF, ICF, IP storage, accountability and reconciliation, Study Procedure, EC communications, Safety reporting, Monitoring visit reporting and follow-up</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Close-Out visit<span class="p">: Study related documents collection, Archival</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">requirement, Investigational Product reconciliation and destruction, Close-Out visit report.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Quality Assurance and Quality Control in  Clinical  Trials: <span class="p">Types of audits, Audit criteria, Audit process</span>, <span class="p">Responsibilities of stakeholders in audit process</span>, <span class="p">Audit follow-up and documentation, Audit resolution and Preparing for FDA inspections, Fraud and misconduct management</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 7pt;text-align: justify;">Data Management</p><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;text-align: justify;">Infrastructure   and   System   Requirement   for   Data Management: <span class="p">Electronic data capture systems</span>, <span class="p">Selection and implementation of new systems</span>, <span class="p">System validation and test</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 84%;text-align: left;">procedures, Coding dictionaries<span class="s2">, </span>Data migration and archival <span class="s2">Clinical  Trial  Data  Management:  </span>Standard  Operating Procedures, Data management plan, CRF &amp; Data base design considerations, Study set-up, Data entry, CRF tracking and corrections, Data cleaning<span class="s2">, </span>Managing laboratory and ADR data<span class="s2">, </span>Data transfer and database lock<span class="s2">, </span>Quality Control and Quality Assurance in CDM<span class="s2">, </span>Data mining and warehousing.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l8"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 26pt;text-indent: -14pt;line-height: 79%;text-align: justify;">Principles and practice of pharmaceutical medicine, Second edition. Authors:Lionel. D. Edward, Aadrew.J.Flether Anthony W Fos , Peter D Sloaier Publisher:Wiley;</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Handbook of clinical research. Julia Lloyd and Ann Raven Ed. Churchill Livingstone</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Principles of Clinical Research edited by Giovanna di Ignazio, Di Giovanna and Haynes.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Central Drugs Standard Control Organization. Good Clinical Practices- Guidelines for Clinical Trials on Pharmaceutical Products in India. New Delhi: Ministry of Health.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">International Conference on Harmonisation of Technical requirements for registration of Pharmaceuticals for human use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice.E6; May 1996.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Ethical Guidelines for Biomedical Research on Human Subjects. Indian Council of Medical Research, New Delhi.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Textbook of Clinical Trials edited by David Machin, Simon Day and Sylvan Green, John Wiley and Sons.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Clinical Data Management edited by R K Rondels, S A Varley, C F Webbs. Second Edition, Jan 2000, Wiley Publications.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: justify;">Goodman &amp; Gilman: JG Hardman, LE Limbard, McGraw Hill Publications.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: justify;">Relevant review articles from recent medical and pharmaceutical literature.</p></li></ol></li></ol><p class="s3" style="padding-top: 3pt;padding-left: 141pt;text-indent: -65pt;line-height: 113%;text-align: left;">PHARMACY PRACTICE PRACTICAL – I (MPP 105P)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Pharmacy Practice practical component includes experiments covering important topics of the courses  Clinical Pharmacy Practice, Pharmacotherapeutics-I, Hospital &amp; Community Pharmacy and Clinical Research.</p><p class="s2" style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">List of Experiments (24)</p><ol id="l9"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Treatment Chart Review (one)</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 11pt;text-align: left;">Medication History Interview (one)</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Patient Medication Counseling (two)</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Drug Information Query (two)</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Poison Information Query (one)</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Lab Data Interpretation (two)</p></li><li data-list-text="7."><p style="padding-left: 27pt;text-indent: -18pt;line-height: 86%;text-align: left;">Presentation of clinical cases of various disease conditions adopting Pharmaceutical Care Plan Model (eight)</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 11pt;text-align: left;">ABC Analysis of a given list of medications (one)</p></li><li data-list-text="9."><p style="padding-top: 1pt;padding-left: 27pt;text-indent: -18pt;line-height: 85%;text-align: left;">Preparation of content of a medicine, with proper justification, for the inclusion in the hospital formulary (one)</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 11pt;text-align: left;">Formulation and dispensing of a given IV admixtures (one)</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of a patient information leaflet (two)</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of Study Protocol (one)</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Preparation of Informed Consent Form (one)</p></li></ol></body></html>
>>>>>>> html
